Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Stroke Risk Scores and Hemostatic Profile in Oral Anticoagulant-naïve (OAC-naïve) Patients With Non-valvular Atrial Fibrillation (NVAF)

NCT06949319 is registered in ClinicalTrials.gov with Nedim Tojaga as lead sponsor.

NCT NCT06949319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06949319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Stroke Risk Scores and Hemostatic Profile in Oral Anticoagulant-naïve (OAC-naïve) Patients With Non-valvular Atrial Fibrillation (NVAF)
Lead sponsor
Nedim Tojaga
Phase
Observational
Overall status
Recruiting
Start date
August 16, 2024
Completion date
September 30, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), atrial fibrillation (prevention of stroke), atrial fibrillation new onset, non valvular atrial fibrillation, stroke, stroke (in patients with atrial fibrillation), thrombosis